<PAGE> 1
OMB APPROVAL
-----------------------
OMB Number 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per form. . . .14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
NS&L BANCORP, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
62937R108
---------
(CUSIP Number)
Jon C. Genisio
c/o NS&L Bancorp, Inc.
111 East Main Street, Neosho, Missouri 64850 (417) 451-0429
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
April 19, 2000
-------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13(d)-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box |_|.
SEC 300 (07-98)
<PAGE> 2
SCHEDULE 13D
CUSIP No. 62937R108 Page 2 of 6 Pages
--------- ----- -----
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Jon C. Genisio
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /_/
(b) /_/
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF;OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) /_/
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 15,203 (not including 4,110 shares subject to options)
SHARES ---------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 15,240
EACH ---------------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 15,203 (not including 4,110 shares subject to options)
WITH ---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
15,240
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
34,553 Shares (including 4,110 shares subject to options)
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |X|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
5.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
<PAGE> 3
Item 1. Security and Issuer.
-------------------
This Schedule 13D relates to the shares of common stock, par value $0.01
per share, of NS&L Bancorp, Inc., ("NS&L Bancorp"), a corporation organized
under the laws of the State of Missouri. The principal executive offices of NS&L
Bancorp are located at 111 East Main Street, Neosho, Missouri 64850.
Item 2. Identity and Background.
-----------------------
This Schedule 13D is being filed by Jon C. Genisio, a director of NS&L
Bancorp. Mr. Genisio's business address is Jon's Pharmacy, Inc., 219 S.
Washington, Neosho, Missouri 64850. Mr. Genisio is a United States citizen.
During the past five years Mr. Genisio has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) nor has he
been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and, as a result of such proceeding, been subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
--------------------------------------------------
13,559 shares were acquired by Mr. Genisio for a total of $114,250. All of
the funds used to purchase these shares were personal funds of Mr. Genisio.
5,040 shares were acquired by Mr. Genisio's spouse for a total of $42,075.
All of the funds used to purchase these shares were personal funds of Mrs.
Genisio.
2,400 shares were acquired by Jon's Pharmacy, Inc. a corporation
controlled by Mr. Genisio, for a total of $27,181. All of the funds used to
purchase these shares were working capital of the corporation.
7,800 shares were acquired by a trust for which Mr. Genisio serves as a
trustee for a total of $70,250.
1,644 shares were acquired by Mr. Genisio as a result of his being awarded
such shares under the NS&L Bancorp, Inc. Management Recognition and Development
Plan. These shares were acquired by Mr. Genisio without payment therefor.
4,110 shares may or will be acquired by Mr. Genisio upon his exercise of
stock options under NS&L Bancorp's 1995 Stock Option Plan, which options are
exercisable within 60 days of April 19, 2000. The exercise price for each of
these shares is $10.78.
3
<PAGE> 4
Item 4. Purpose of Transaction.
-----------------------
The shares covered by this statement are being held for investment
purposes. Depending upon a continuing assessment and upon future developments,
the reporting person may determine from time to time or at any time to purchase
additional shares of NS&L Bancorp or sell or otherwise dispose of some of the
shares. Other than in his capacity as a member of NS&L Bancorp's Board of
Directors, Mr. Genisio has no plans which relate to or would result in:
(a) an extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving NS&L Bancorp or any of its
subsidiaries;
(b) a sale or transfer of a material amount of assets of NS&L Bancorp or
any of its subsidiaries;
(c) any change in the present Board of Directors or management of NS&L
Bancorp, including any plans or proposals to change the number or
term of directors or to fill any existing vacancies on the board;
(d) any material change in the present capitalization or dividend policy
of NS&L Bancorp;
(e) any other material change in NS&L Bancorp's business or corporate
structure;
(f) changes in NS&L Bancorp's charter or bylaws or instruments
corresponding thereto or other actions which may impede the
acquisition of control of NS&L Bancorp by any person;
(g) causing a class of securities of NS&L Bancorp to be delisted from a
national securities exchange or to cease to be authorized to be
quoted in an inter-dealer quotation system of a registered national
securities association;
(h) a class of equity securities of NS&L Bancorp becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Act;
or
(i) any action similar to any of these enumerated above.
4
<PAGE> 5
Item 5. Interest in Securities of the Issuer.
------------------------------------
(a) 34,553 shares are beneficially owned by the reporting person as of
the date of this statement, including 4,110 shares that Mr. Genisio
has the right to acquire pursuant to exercisable options,
representing 5.0% of the total shares issued and outstanding of NS&L
Bancorp's common stock. The aggregate amount reported as
beneficially owned in Row 11 does not include shares held in trust
by the Neosho Savings and Loan Association, F.A. Employee Stock
Ownership Plan of which Mr. Genisio is a trustee. Mr. Genisio
disclaims beneficial ownership of the shares held in trust by such
plan.
(b) The reporting person has sole voting and dispositive power over
15,203 shares, not including 4,110 shares that Mr. Genisio has the
right to acquire pursuant to exercisable options.
The reporting person has shared voting and dispositive power over
15,240 shares. This amount includes 5,040 shares owned by Mr.
Genisio's spouse, 2,400 shares owned by Jon's Pharmacy, Inc. and
7,800 shares owned by a trust for which Mr. Genisio serves as a
trustee.
(c) The reporting person has not acquired any shares of NS&L Bancorp
common stock within the past 60 days.
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings, or Relationships with Respect
----------------------------------------------------------------------
to Securities of the Issuer.
---------------------------
There are not contracts, arrangements, understandings or relationships
between Mr. Genisio and any person with respect to any securities of
NS&L Bancorp.
Item 7. Material to be Filed as Exhibits.
--------------------------------
None.
5
<PAGE> 6
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
By: /s/ Jon C. Genisio
----------------------------------
Jon C. Genisio
Date: May 31, 2000
6
